GLUE Operating Cash Flow (Statement)
Monte Rosa Therapeutics Inc · Operating Cash Flow (Statement)
GLUE Operating Cash Flow (Statement)
Latest reported-$24.07Mperiod ending
GLUE TTM Cash from Operations (-$23.05M → -$24.07M)
TTM operating cash flow (statement)
High-resolution chart · PNG
GLUE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -24,069,000 | |
| -14,675,000 | |
| -22,798,000 | |
| 149,138,000 | |
| 27,716,000 | |
| 34,669,000 | |
| 41,996,000 | |
| -57,292,000 | |
| -61,004,000 | |
| -58,561,000 | |
| -43,802,000 | |
| -97,397,000 | |
| -93,291,000 | |
| -88,468,000 | |
| -92,466,000 | |
| -82,677,000 | |
| -79,871,000 | |
| -72,952,000 | |
| -59,363,000 | |
| -53,765,000 | |
| -42,862,000 | |
| -33,492,000 | |
| -23,053,000 |